Publication

Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Jessica R. Spengler, Centers for Disease Control and PreventionM Kelly Keating, Centers for Disease Control and PreventionAnita McElroy, Emory UniversityMarko Zivcec, Centers for Disease Control and PreventionJoAnn D Coleman-McCray, Centers for Disease Control and PreventionJessica R. Harmon, Centers for Disease Control and PreventionBrigid C. Bollweg, Centers for Disease Control and PreventionCynthia S Goldsmith, Centers for Disease Control and PreventionEric Bergeron, Centers for Disease Control and PreventionJames G. Keck, The Jackson LaboratorySherif R. Zaki, Centers for Disease Control and PreventionStuart Nichol, Emory UniversityChristina F. Spiropoulou, Centers for Disease Control and Prevention
Language
  • English
Date
  • 2017-12-01
Publisher
  • Oxford University Press (OUP): Policy B - Oxford Open Option C
Publication Version
Copyright Statement
  • Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0022-1899
Volume
  • 216
Issue
  • 11
Start Page
  • 1386
End Page
  • 1397
Grant/Funding Information
  • This work was partially supported by an appointment to the Research Participation Program at the CDC administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the CDC, by the National Institutes of Health (loan repayment award to J. R. S.), and by a CDC foundation project funded by the National Institute of Allergy and Infectious Diseases (grant R01AI109008 to E. B.).
Supplemental Material (URL)
Abstract
  • Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral hemorrhagic disease seen exclusively in humans. Central nervous system (CNS) infection and neurological involvement have also been reported in CCHF. In the current study, we inoculated NSG-SGM3 mice engrafted with human hematopoietic CD34+ stem cells with low-passage CCHF virus strains isolated from human patients. In humanized mice, lethal disease develops, characterized by histopathological change in the liver and brain. To date, targets of neurological infection and disease have not been investigated in CCHF. CNS disease in humanized mice was characterized by gliosis, meningitis, and meningoencephalitis, and glial cells were identified as principal targets of infection. Humanized mice represent a novel lethal model for studies of CCHF countermeasures, and CCHF-associated CNS disease. Our data suggest a role for astrocyte dysfunction in neurological disease and identify key regions of infection in the CNS for future investigations of CCHF.
Author Notes
  • Correspondence: J. R. Spengler, DVM, PhD, MPH, Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30333 (JSpengler@cdc.gov).
Keywords
Research Categories
  • Biology, Cell
  • Health Sciences, Pathology
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items